Tesla Rival Nio Doesn’t Lower Its Annual Forecast Due to Coronavirus, NIO Stock Up 12%
Tesla rival Nio hasn’t lowered its annual forecast as a result of the coronavirus. At the time of writing, NIO stock is 12% up.
Breaking news coverage from cryptocurrency world about key figures, exchanges, startups, investment, applications, regulation and more.
Tesla rival Nio hasn’t lowered its annual forecast as a result of the coronavirus. At the time of writing, NIO stock is 12% up.
Barclays reported that its Q1 net profit had plunged 42% year-on-year and it decided to take a credit impairment charge. Meanwhile, BCS stock is up.
Alphabet (GOOG) stock price is rising today after the company has published its earnings report for the first quarter of this year. The results are better than it was expected.
Standard Chartered is currently bullish about its chances for earnings, regardless of the coronavirus pandemic. STAN stock is 5% up now.
Blockchain startup Aladiex has introduced its ecosystem. This will help MSME business to get the incentives that they need to grow.
The COVID-19 pandemic has put a dent of Facebook’s advertising revenue as businesses turn conservative on their marketing spends. However, analysts are hopeful that Facebook will make a good recovery in the coming months. FB stock is rising now.
With the Bitcoin halving event less than 13 days away, the BTC price rally continues. The coin has hit $8,000 with the bulls setting new higher highs striving to break strong resistances.
Ford (F) stock price fell about 5% at the news of its losses in Q1. Poor earnings results are mostly related to the COVID-19 situation.
TON OS that is expected to launch in the nearest future will not serve as an alternative to the existing operating systems. Instead, it will be an add-in for devices to support apps based on blockchain.
Moderna Inc proceeds ahead for the Phase 2 clinical trial of its vaccine to fight with the coronavirus. The company has received a nod from the Food and Drug Administration to proceed ahead with the project. MRNA stock is in the green in the pre-market.